Biology and chemoprevention of lung cancer

Chest
J M Siegfried

Abstract

Advances in cell and molecular biology have increased our understanding of the multiple events that lead to the development of lung cancer. The field cancerization theory suggests that multiple genetic abnormalities occur throughout the respiratory epithelium as a result of long-term carcinogen exposure. Because of this diffuse injury throughout the lung, systemic therapy that could halt or reverse the development of cancerous changes may be effective in preventing lung cancer. This article summarizes the chemoprevention agents that have been used in clinical trials to prevent lung cancer of the head and neck. Biomarkers that have been suggested as intermediate end points in evaluating the effectiveness of chemoprevention agents are also discussed.

References

Oct 1, 1989·The Journal of Clinical Investigation·S M AguayoY E Miller
Feb 1, 1989·The Journal of Pathology·J R GosneyA F Blakey
May 1, 1988·Cancer Letters·H F StichM K Nair
Dec 11, 1986·The New England Journal of Medicine·W K HongC Vaughan
Jan 1, 1995·Journal of Occupational and Environmental Medicine·A Hirvonen
Mar 1, 1995·Oncology·S E BennerW K Hong
Feb 25, 1993·The New England Journal of Medicine·W Hryniuk
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B E JohnsonG E Richardson
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S E BennerW K Hong
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M BollaA Laplanche
Apr 14, 1994·The New England Journal of Medicine·UNKNOWN Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S LeeH A Fritsche
Jan 7, 1993·The New England Journal of Medicine·S M LippmanW K Hong

❮ Previous
Next ❯

Citations

May 2, 2000·American Journal of Preventive Medicine·C L Rock
Apr 28, 1999·Free Radical Biology & Medicine·V P PalaceP K Singal
Jul 17, 1999·Current Opinion in Pulmonary Medicine
Jan 14, 2009·Cancer Prevention Research·Katrina SteilingAvrum Spira
Jan 15, 1999·Hematology/oncology Clinics of North America·M You, G Bergman
Sep 27, 2001·Veterinary Pathology·T H MarchS A Belinsky
Oct 19, 2012·The Cochrane Database of Systematic Reviews·Marcela Cortés-JofréXavier Bonfill Cosp
Jul 17, 1999·Current Opinion in Pulmonary Medicine·G A Lillington

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.